Colon Cancer Equipment
-
Manufactured by Veracytebased in FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for ...
-
Manufactured by BTNX Inc.based in CANADA
The Rapid Response Fecal Immunochemical Test (FIT) Mailer is a paper kit designed to be handed to patients and used in conjunction with the Rapid ResponseTM FIT Test for at-home collection of spontaneously passed stool (SPS) specimens. This easy collection method increases patient compliance and ensures an appropriate sample from which the patient can collect. ...
-
Manufactured by BTNX Inc.based in CANADA
The Rapid Response Fecal Immunochemical Test (FIT) Cassette is a rapid, qualitative test for the determination of human occult blood in feces, to aid in the early detection of gastrointestinal problems such as colorectal cancer. Traditional guaiac-based methods to detect fecal occult blood lack sensitivity and specificity, and also have ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used as treatment or post-surgery adjuvant therapy for metastatic colorectal cancer, colon cancer, advanced or metastatic gastric cancer, and stage II and III gastric ...
-
Manufactured by Immunostics, Incbased in USA
Greater sensitivity than traditional guaiac-based methods. Increased specificity to lower GI bleeding makes hema-screen SPECIFIC GOLD an ideal tool for colon cancer ...
-
Manufactured by Hipro Biotechnology Co.,Ltd.based in CHINA
Zoan Fecal Occult Blood / Transferrin Combo Test Kit. Highlights:Early Bowel Cancer Screening, No pain & Non-invasive Detection, Fast Result in 5 Minutes, Home Test, Combined Test-2 result in 1 test, Easy operation with integrated design, Clean and Odourless, High accuracy&Specificity. Early screening of Colon Cancer can save ...
-
based in AUSTRALIA
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, LGR5+ expression ...
-
Manufactured by EntroGen, Inc.based in USA
PIK3CA Mutations and CancerThe PIK3CA gene encodes the p110a subunit of phosphatidyl 3-kinase, a lipid kinase involved in cell growth, proliferation, motility and survival. It has a central role in the PI3K-AKT-mTOR pathway. Somatic mutations in the PIK3CA gene have been implicated in the pathogenesis of several cancers, including colon ...
-
Manufactured by CTK Biotech, Inc.based in USA
doesn’t indicate the type of cancer the patient may have, CEA levels increase in rectal colon cancer patients. After successful resection of the tumor, CEA levels will decrease back to normal. Understanding the CEA blood levels in patients is therefore useful in cancer screening and treatment ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
such as Gefitinib (Iressa) or Erlotinib (Tarceva). Recently, KRAS mutation is often detected in colorectal cancer and may be related with drug response to Cetuximab (Erbitux) or Panitumumab (Vectibix) that is used for colon cancer therapy. Therefore, examination of KRAS mutation is needed to determine drug resistance of patients with colorectal ...
-
Manufactured by Sysmex Partec GmbHbased in GERMANY
Precise lymph node analysis providing accurate staging, Reliable diagnostic information for therapy decision, High flexibility in multi-cancer application (CE-marked for breast, colon and gastric cancer). Axillary management and the relevance of sentinel lymph node biopsy (SLNB) have undergone major changes in the last years. Clinical ...
-
Manufactured by OncoQR ML GmbHbased in AUSTRIA
Lead candidate TYG100 (formerly OQR100, out-licensed to TYG oncology Ltd.) is an “Active Checkpoint Control Immunotherapy (ACCI)” for the treatment of gastroenterological cancers such as pancreatic, stomach, colon, and gastro-esophageal cancer. The immunogen of TYG100 contains a small part of G17 (little ...
-
Manufactured by Provista Diagnosticsbased in USA
Limitations of Current Cancer Screening: Screening tests for cancers in general, and breast, colon, and lung cancers specifically, have well known constraints and compliance shortcomings. Either the procedures are too invasive or they lack accuracy or the most effective diagnostics remain too expensive for widespread adoption for ...
-
Manufactured by Santa Cruz Biotechnology, Inc.based in USA
Bafilomycin A1® is a macrolide antibiotic and potent and selective inhibitor of vacuolar-type H+ ATPase ...
-
based in UNITED KINGDOM
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a ...
-
Manufactured by Affimed GmbHbased in GERMANY
AFM24, an EGFR-directed ICE® (innate cell engager) molecule, represents a distinctive mechanism that engages innate immune cells by recruiting NK cells and macrophages to the site of the tumor for effective and efficient tumor-cell killing. Potential to treat various solid tumor types with a more acceptable safety profile while remaining immune to the challenge of ...
-
Manufactured by Affimed GmbHbased in GERMANY
Lighting the way with clinical results: we are creating success with monotherapies and combination therapies. AFM13, a first-in-class ICE (innate cell engager) molecule targeting patients with CD30-positive lymphomas,4 showed antitumor responses in a Phase 1/2 trial as a monotherapy in 15 patients with T-cell lymphomas and cutaneous involvement (44% ORR).5 When used in combination with allogeneic ...
-
Manufactured by Immundiagnostik AGbased in GERMANY
Immundiagnostik has developed a patented technology for quantitative evaluation of rapid tests. This enables the evaluation of rapid tests, also known as lateral flow tests, using a smartphone and its camera. Photometric methods can be used to analyse the rapid tests. This is independent of the sample type, i.e. blood, stool or saliva samples are just a few test types that can be evaluated with ...
-
Manufactured by CDx Diagnostics Inc.based in USA
A routine diagnostic test that empowers doctors to help prevent oral cancer and save lives. OralCDx allows you to painlessly test any white or red spot in the mouth to rule out the possibility that precancerous cells are present. If dysplasia is found, the cells can typically be removed in order to stop the progression of oral cancer. ...
-
Manufactured by BriaCell Therapeutics Corp.based in CANADA
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that Bria-IMT™/Bria-OTS™, exert their action by stimulating the antigen-presentation system (i.e. the system that presents antigen material on ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you